Enacitib

Enacitib uses and dosage

Enacitib (Enasidenib), generic Idhifa is a prescription medicine used to treat patients with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatments. Enasidenib works by helping patient's bone marrow grow normal blood cells so patient will need fewer blood transfusions. Enacitib is manufactured by Ziska Pharma Ltd. in Bangladesh. Enasidenib has to take orally usually once daily with/ without food.

Enacitib side effects

The most common adverse reactions of Enasidenib are: Diarrhea, nausea, vomiting, change in taste, or loss of appetite

Originator brand

Idhifa by Bristol myers squibb

Made by

Ziska Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.